Zai Lab Limited ADRZLAB
Price$26.34Intrinsic value$37.3842% above price

Outlook & Key Dates

Estimates, guidance, catalysts, and upcoming events

Analyst Estimates Learn more →
5-Yr Fwd EPS Growth
3.6%projected annual EPS growth
As of 27 Aug 2026
Analyst Coverage
12analysts covering
Consensus: PositiveAs of 18 Aug 2026
FY EPS (est.)
-$2.29next fiscal year
As of 18 Aug 2026
Monitoring Framework
Key Performance Indicators
Total Product Revenue Quarterly95.6M
ZEJULA Product Revenue Quarterly30M
VYVGART Product Revenue Quarterly17.6M
Cash and Cash Equivalents (including short-term investments and restricted cash) Quarterly761.3M
Watch Items
  • Zocilurtatug pelitecan (zoci) registrational DLLEVATE trial enrollmentTrigger: Completion of enrollment in the first half of 2027
  • KarXT commercial launch in ChinaTrigger: Launch execution in Q2 2026
Sign in / Sign up to read more

Research as of 20 Jun 2026

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.